Skip to main content
Adam Spivak, MD, Infectious Disease, Salt Lake City, UT

Adam Mitchell Spivak MD


Assistant Professor, Internal Medicine, University of Utah School of Medicine

Join to View Full Profile
  • 50 N Medical DrSalt Lake City, UT 84132

  • Phone+1 801-585-2031

  • Fax+1 801-585-3377

Dr. Spivak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 2007 - 2011
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2002 - 2005
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2002

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 2011 - 2026
  • MD State Medical License
    MD State Medical License 2005 - 2011
  • CO State Medical License
    CO State Medical License 2005 - 2007
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Sex Influences SAMHD1 Activity and Susceptibility to HIV-1 in Primary Human Macrophages  
    Adam Spivak, MD, The Journal of Infectious Diseases

Press Mentions

  • 15 Signs You May Have Already Had Covid-19, Doctors Reveal
    15 Signs You May Have Already Had Covid-19, Doctors RevealSeptember 23rd, 2022
  • University of Utah Health Seeking COVID-19 Patients for Treatment Trial
    University of Utah Health Seeking COVID-19 Patients for Treatment TrialMarch 26th, 2021
  • First Edition: March 26, 2021
    First Edition: March 26, 2021March 26th, 2021
  • Join now to see all

Grant Support

  • Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistenceFRED HUTCHINSON CANCER CENTER2024–2029
  • Discovering New HIV-1 Latency Reversal Agents from Euphorbia SpeciesUNIVERSITY OF UTAH2022–2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: